News - Arena Pharmaceuticals


Current filters:

Arena Pharmaceuticals

Popular Filters

Arena and Eisai release data on obesity drug candidate lorcaserin to be used in CRL response


USA-based Arena Pharmaceuticals (Nasdaq: ARNA) and Japanese partner Eisai (TYO: 4523) announced the completion…

Arena PharmaceuticalsEisailorcaserinMetabolicsPharmaceuticalResearch

Down but not out - obesity drugs continue journey towards approval


Recent studies have shown that the chances of US Food and Drug Administration approval for early-stage…

Arena PharmaceuticalsContravelorcaserinMetabolicsOrexigen TherapeuticsPharmaceuticalRegulation

Back to top